Pfizer Cancer Drug Gets Wider Approval
5th Oct 2005, 22:09 GMT
Pfizer said the FDA expanded the approval of its Aromasin breast cancer drug to include use of the therapy following surgery for early breast cancer.
Pfizer Cancer Drug Gets Wider Approval related news:
- FDA Approves Pfizer Request To Market Breast Cancer Drug ... — Pfizer
- FDA OKs Pfizer's Lipitor for use in diabetics — Health News Online - Medical and health information and tools from Armenian Medical Network
- Market Pulse: Pfizer gets FDA ok for Aromasin as adjuvant treatment — Operations-Related News from StratCenter.com
- Pfizer breast cancer drug gets go-ahead — CNN/Money Recently Published/Updated
- Clinical trial of cancer drug deferred — The Irish Times' Irish Top Stories
- Pfizer Plays A Guessing Game — Forbes.com Science and Medicine News
- Mylan Labs Puts Pressure on Pfizer — TheStreet.com
- Vaccine proves effective for cervical cancer — The Daily Herald
- Mylan gets final OK for generic of Norvasc — SacBee -- Business News
- Mylan gets US OK for generic of Norvasc — Pharmaceuticals News from StratCenter.com
Latest news from Operations-Related News from StratCenter.com:
- Senior Housing Properties Trust Announces Proposed Public Offering of 5 mln Common Shares
- King Not Loving Its Shareholders
- Sepracor says asthma drug data is favorable
- Sepracor Presents Data on Asthma Drug
- Dr Reddy's Registers to List Shares
- PolyMedica Corp CEO to Ring the NASDAQ Stock Market Opening Bell
- Biovail to Present at the CSFB 2006 Healthcare Conference
- Genelabs reports lower Q3 loss
- Solexa posts narrowed Q3 loss
- Abbott's Humira Positive in 2 Studies